Reveal for T1D

Accelerated Type 1 diabetes (T1D) detection that meets you where you are

Proactive Care Powered by Precision Identification

85-90% of individuals with Type 1 diabetes are diagnosed at the most advanced stage1, when symptoms are severe and the risk of complications is highest. Current screening recommendations lack specificity for early detection, and most cases are missed until symptoms develop.

Reveal for T1D leverages advanced AI and existing EHR data to efficiently identify patients at higher risk for presymptomatic, early-stage Type 1 diabetes – enabling earlier diagnosis, and intervention when it matters most.

Proactive Care Powered by Precision Identification

85-90% of individuals with Type 1 diabetes are diagnosed at the most advanced stage1, when symptoms are severe and the risk of complications is highest. Current screening recommendations lack specificity for early detection, and most cases are missed until symptoms develop.

Reveal for T1D leverages advanced AI and existing EHR data to efficiently identify patients at higher risk for presymptomatic, early-stage Type 1 diabetes – enabling earlier diagnosis, and intervention when it matters most.

How Reveal for T1D Works

Reveal for T1D enables earlier detection without disruption, aligning with your existing clinical workflows to drive better outcomes.

Identify

Advanced clinical AI analyzes existing patient data and finds those at statistically higher risk for Type 1 diabetes.

Prioritize

Risk-stratified patients surfaced in a simple, manageable list that plugs into your existing workflows.

Engage

Care coordinators efficiently reach out through established channels, inviting patients for individual Type 1 diabetes screening.

Diagnose

Diagnose Type 1 diabetes sooner and help patients avoid life-threatening complications by fast-tracking interventions.

47x improved screening efficiency

Smarter Screening, Greater Impact

Reveal for T1D helps top healthcare organizations maximize their current resources and clinical expertise, making early-stage detection routine and scalable.

Reveal for T1D Dashboard_Desktop

  • Amplify Existing Resources: Uncover more at-risk patients without additional FTEs or tiresome manual chart reviews.

  • Clinical Precision: Targets presymptomatic and early-stage T1D based on current endocrinology guidelines and real-world data.

  • Operational Efficiency: Integrates natively with your existing clinical and patient engagement systems, enabling streamlined care pathways and measurable workflow gains.

  • Innovative Care: Be at the forefront of advancing Type 1 diabetes care, contribute to pioneering research, and lead broader disease understanding.

  • Rapid Deployment: Deploy in weeks, not months, with standards-driven integration and enterprise-level security.

  • Financial & Clinical ROI: Accelerate value-based care metrics, reduce downstream complications, and generate new service line revenue from earlier intervention.

47x improved screening efficiency

Smarter Screening, Greater Impact

Reveal for T1D helps top healthcare organizations maximize their current resources and clinical expertise, making early-stage detection routine and scalable.

Reveal for T1D Dashboard_Desktop

  • Amplify Existing Resources: Uncover more at-risk patients without additional FTEs or tiresome manual chart reviews.

  • Clinical Precision: Targets presymptomatic and early-stage T1D based on current endocrinology guidelines and real-world data.

  • Operational Efficiency: Integrates natively with your existing clinical and patient engagement systems, enabling streamlined care pathways and measurable workflow gains.

  • Innovative Care: Be at the forefront of advancing Type 1 diabetes care, contribute to pioneering research, and lead broader disease understanding.

  • Rapid Deployment: Deploy in weeks, not months, with standards-driven integration and enterprise-level security.

  • Financial & Clinical ROI: Accelerate value-based care metrics, reduce downstream complications, and generate new service line revenue from earlier intervention.

Try Reveal for T1D at no-cost for up to a year

Try Reveal for T1D at no-cost for up to a year

The Urgency of Earlier Type 1 Diabetes Detection

Type 1 diabetes is an autoimmune disease where the immune system attacks insulin-producing beta cells in the pancreas, leading to life-long insulin dependence. The disease progresses through three distinct stages, all marked by changes in immune response and blood sugar control—almost all individuals eventually progressing to symptomatic, clinically diagnosed diabetes without early intervention.

Stage 1
Normal blood sugar

The body has started to develop antibodies against insulin-producing cells, but blood sugar is still normal and there are no symptoms.

Stage 2
Abnormal blood sugar

More insulin-producing cells are affected. Blood sugar levels begin to rise, though there are still no noticeable symptoms.

Stage 3
Clinical diagnosis

Most insulin-producing cells are lost. Blood sugar is high and diabetes symptoms such as increased thirst, urination, or weight loss are present.

Early diagnosis prevents life-threatening diabetic ketoacidosis, reduces risk of severe complications, and enables prompt initiation of insulin therapy and patient education

Delayed diagnosis can result in hospitalizations and long-term organ damage

The Urgency of Earlier Type 1 Diabetes Detection

Type 1 diabetes is an autoimmune disease where the immune system attacks insulin-producing beta cells in the pancreas, leading to life-long insulin dependence. The disease progresses through three distinct stages, all marked by changes in immune response and blood sugar control—almost all individuals eventually progressing to symptomatic, clinically diagnosed diabetes without early intervention.

Stage 1
Normal blood sugar

The body has started to develop antibodies against insulin-producing cells, but blood sugar is still normal and there are no symptoms.

Stage 2
Abnormal blood sugar

More insulin-producing cells are affected. Blood sugar levels begin to rise, though there are still no noticeable symptoms.

Stage 3
Clinical diagnosis

Most insulin-producing cells are lost. Blood sugar is high and diabetes symptoms such as increased thirst, urination, or weight loss are present.

Featured Type 1 Diabetes Resources

Fact Sheet

Type 1 Diabetes Fact Sheet

Understand the basics behind Type 1 diabetes: what it is, how it progresses, and industry recommended screening approaches.

Reveal for T1D Main Header
Solution Overview

Reveal for T1D

A one page solution overview document that you can download and socialize to your team.

Early Detection Saves Lives

Bring the power of clinical AI to your organization today—so you can reveal hidden patient risks, focus your resources, and deliver higher clinical value, more proactive patient care.

Get In Touch